about
5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylationOverexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinomaHigh expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting METYPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis.HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma.Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications.SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinomaDifferential genome-wide profiling of alternative polyadenylation sites in nasopharyngeal carcinoma by high-throughput sequencingIdentification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapyTIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinomamA-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progressionNFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 TranscriptionReduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinomaHypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 StabilityFNDC3B 3'UTR shortening escapes from miRNA-mediated gene repression and promotes NPC progressionRAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma
P50
Q27312329-D9F9FF37-843C-4058-A53C-B7DD1ECAF914Q33712856-51790201-44B6-462A-A6BA-09D454B3D580Q35225191-DE950B1A-AF19-4C8D-A82D-D4A205270148Q35583857-C340CE06-4D1A-417D-87BA-64EE9372241AQ36080149-4528DB02-E9C4-429A-BE3F-CCD6BFC0CCDCQ36156092-2857E47C-CA17-4950-9155-4E76DCBF9A18Q36347188-8758317A-3CB7-46C4-96B9-DF48A030F9D4Q37085002-AB51183F-F17C-4963-924F-B479C6F1EBD7Q37465789-2105E5D1-04AE-4853-84FE-D6514CDA4520Q37630359-6637E590-0878-45F8-9FBB-279C59C330CCQ37744968-93F4E7CD-529C-44A9-A368-FA43319F63B3Q38884781-7BAEBCC7-996D-4182-856D-D3702D9757AEQ38907464-6910D952-FE8A-47B1-BB1C-AC1CD35AB269Q38967416-C5FC89A7-DD9F-4740-981A-B0AC0C714319Q41173680-E7E60546-ACD5-4291-8449-5C7BBB9AD2D2Q42668878-4C1A8788-D1B0-493E-AF0B-1E4A796D5429Q48152319-F1EDE402-5E9D-461E-B2E4-97BADA36D21EQ49887992-EBC54B57-444D-4508-882B-181A591C2D81Q53359622-65CE8BB5-ED13-4FB2-882B-CF3E4306B8B8Q55282550-1E9D19C2-0DD1-4059-AB6E-6B586CE2837BQ57796306-C00BABF8-1CA4-4114-BF08-7C9426542D57Q57797605-01AE41AF-93F2-4BE7-BDB4-87F872CEE5FFQ58574577-2504FDAB-60D3-4A88-A11B-EAF61C9CC490Q58741597-B9CA4BD4-6EE5-4B9C-961F-E7C6DF1B5AA6Q59792009-C7F58C68-8584-4815-AC84-EE7F360BC64EQ64250168-5343161D-66C3-4484-A84F-7790DF75C603Q85888649-EBB45CE3-3298-433D-AC59-0DE9B328E868Q90680237-995E153B-E828-4BA8-809F-05F4D3F47E83Q90787314-DDC1DE99-FDD2-4057-87CD-0CB1158F2BBDQ91068415-01B64BF6-AA3B-49E5-BEA9-4DE677EAA2C3
P50
description
researcher (ORCID 0000-0001-8654-3636)
@en
name
Na Liu
@en
type
label
Na Liu
@en
prefLabel
Na Liu
@en
P31
P496
0000-0001-8654-3636